rs138859323

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_014795.4(ZEB2):​c.489C>T​(p.Ile163Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00301 in 1,614,212 control chromosomes in the GnomAD database, including 50 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0030 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0030 ( 50 hom. )

Consequence

ZEB2
NM_014795.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 0.747
Variant links:
Genes affected
ZEB2 (HGNC:14881): (zinc finger E-box binding homeobox 2) The protein encoded by this gene is a member of the Zfh1 family of 2-handed zinc finger/homeodomain proteins. It is located in the nucleus and functions as a DNA-binding transcriptional repressor that interacts with activated SMADs. Mutations in this gene are associated with Hirschsprung disease/Mowat-Wilson syndrome. Alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Jan 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 2-144404939-G-A is Benign according to our data. Variant chr2-144404939-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 95637.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-144404939-G-A is described in Lovd as [Likely_benign]. Variant chr2-144404939-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.747 with no splicing effect.
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.051 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ZEB2NM_014795.4 linkuse as main transcriptc.489C>T p.Ile163Ile synonymous_variant 5/10 ENST00000627532.3 NP_055610.1 O60315-1
ZEB2NM_001171653.2 linkuse as main transcriptc.417C>T p.Ile139Ile synonymous_variant 4/9 NP_001165124.1 O60315-2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ZEB2ENST00000627532.3 linkuse as main transcriptc.489C>T p.Ile163Ile synonymous_variant 5/101 NM_014795.4 ENSP00000487174.1 O60315-1

Frequencies

GnomAD3 genomes
AF:
0.00299
AC:
455
AN:
152222
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000676
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00536
Gnomad ASJ
AF:
0.0173
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00393
Gnomad FIN
AF:
0.000565
Gnomad MID
AF:
0.0538
Gnomad NFE
AF:
0.00335
Gnomad OTH
AF:
0.00669
GnomAD3 exomes
AF:
0.00372
AC:
934
AN:
251314
Hom.:
4
AF XY:
0.00412
AC XY:
559
AN XY:
135830
show subpopulations
Gnomad AFR exome
AF:
0.000308
Gnomad AMR exome
AF:
0.00361
Gnomad ASJ exome
AF:
0.0192
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00376
Gnomad FIN exome
AF:
0.000277
Gnomad NFE exome
AF:
0.00392
Gnomad OTH exome
AF:
0.00684
GnomAD4 exome
AF:
0.00301
AC:
4406
AN:
1461872
Hom.:
50
Cov.:
31
AF XY:
0.00326
AC XY:
2371
AN XY:
727236
show subpopulations
Gnomad4 AFR exome
AF:
0.00221
Gnomad4 AMR exome
AF:
0.00387
Gnomad4 ASJ exome
AF:
0.0199
Gnomad4 EAS exome
AF:
0.000126
Gnomad4 SAS exome
AF:
0.00402
Gnomad4 FIN exome
AF:
0.000880
Gnomad4 NFE exome
AF:
0.00230
Gnomad4 OTH exome
AF:
0.00588
GnomAD4 genome
AF:
0.00298
AC:
454
AN:
152340
Hom.:
0
Cov.:
32
AF XY:
0.00294
AC XY:
219
AN XY:
74488
show subpopulations
Gnomad4 AFR
AF:
0.000698
Gnomad4 AMR
AF:
0.00536
Gnomad4 ASJ
AF:
0.0173
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00394
Gnomad4 FIN
AF:
0.000565
Gnomad4 NFE
AF:
0.00335
Gnomad4 OTH
AF:
0.00662
Alfa
AF:
0.00448
Hom.:
0
Bravo
AF:
0.00311
Asia WGS
AF:
0.00346
AC:
12
AN:
3478
EpiCase
AF:
0.00583
EpiControl
AF:
0.00694

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Benign, criteria provided, single submitterclinical testingGeneDxMar 09, 2012This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoSep 30, 2015- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Sep 13, 2013- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsJun 26, 2017- -
Mowat-Wilson syndrome Benign:3
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabNov 07, 2021- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 25, 2024- -
not provided Benign:3
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenNov 01, 2024ZEB2: BP4, BP7, BS1, BS2 -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsApr 19, 2016This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
ZEB2-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesOct 25, 2023This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
8.5
DANN
Benign
0.88

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs138859323; hg19: chr2-145162506; COSMIC: COSV57955598; COSMIC: COSV57955598; API